Pharmacokinetic evaluation and therapeutic activity of bendamustine in B-cell lymphoid malignancies

Author： Korycka-Wołowiec Anna   Robak Tadeusz  

Publisher： Informa Healthcare

ISSN： 1742-5255

Source： Expert Opinion on Drug Metabolism and Toxicology, Vol.8, Iss.11, 2012-11, pp. : 1455-1468

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cell Death Targeting Therapies in B Lymphoid Malignancies

By  

Current Drug Targets, Vol. 11, Iss. 7, 2010-07 ,pp. : 769-780

Bentham Science Publishers

Access to resources Recommend Favorite

Tyrosine kinase inhibitors as potential drugs for B-cell lymphoid malignancies and autoimmune disorders

By Robak Tadeusz   Robak Ewa  

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 7, 2012-07 ,pp. : 921-947

Informa Healthcare

Access to resources Recommend Favorite

The NF-κB signalling pathway: a therapeutic target in lymphoid malignancies?

By Stoffel Archontoula  

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 5, 2005-10 ,pp. : 1045-1061

Informa Healthcare

Access to resources Recommend Favorite

An Update on the Xenograft and Mouse Models Suitable for Investigating New Therapeutic Compounds for the Treatment of B-Cell Malignancies

By  

Current Pharmaceutical Design, Vol. 14, Iss. 21, 2008-07 ,pp. : 2023-2039

Bentham Science Publishers

Access to resources Recommend Favorite

Idiotype Vaccines for Human B-Cell Malignancies

By  

Current Pharmaceutical Design, Vol. 16, Iss. 3, 2010-01 ,pp. : 300-307

Bentham Science Publishers

Access to resources Recommend Favorite